PSMA PET Staging is Advised for All High-Risk Patients With Localized Prostate Cancer
International Journal of Radiation Oncology*Biology*Physics · 2024
DOI: 10.1016/j.ijrobp.2024.06.031 ↗Kurz gefasst
Editorial in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2024. Verfasst von Declan G Murphy und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, University of …. Hauptthemen laut MEDLINE: Neoplasm Staging, Prostatic Neoplasms. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia. Electronic address: declan.…
- Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia.
Zitieren
APA
Murphy, D. G., & Emmett, L. (2024). PSMA PET Staging is Advised for All High-Risk Patients With Localized Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2024.06.031
Vancouver
Murphy DG, Emmett L. PSMA PET Staging is Advised for All High-Risk Patients With Localized Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 2024. doi:10.1016/j.ijrobp.2024.06.031
BibTeX
@article{Murphy2024,
author = {Murphy, Declan G and Emmett, Louise},
title = {PSMA PET Staging is Advised for All High-Risk Patients With Localized Prostate Cancer},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2024},
doi = {10.1016/j.ijrobp.2024.06.031}
}
EUVIMED